Short Interest in Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Expands By 127.4%

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) saw a significant growth in short interest in February. As of February 28th, there was short interest totalling 48,900 shares, a growth of 127.4% from the February 13th total of 21,500 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

Laboratorios Farmaceuticos Rovi Stock Performance

Shares of OTCMKTS:LABFF opened at C$65.86 on Friday. Laboratorios Farmaceuticos Rovi has a 52-week low of C$65.86 and a 52-week high of C$65.86. The firm has a fifty day moving average of C$65.86 and a 200 day moving average of C$76.94.

Laboratorios Farmaceuticos Rovi Company Profile

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.